SEARCH

SEARCH BY CITATION

References

  • Agresti A. (1992) A survey of exact inference for contingency tables. Statist. Sci. 7, 131153.
  • Arnold S. (1990) Mathematical Statistics. Prentice Hall International Inc., Englewood Cliffs, USA.
  • Bauer R., Mayr A., Lederer W., Needham P. L., Kilpatrick I. C., Fleischhacker W. W. and Marksteiner J. (2000) Further evidence that behavioral tests and neuropeptide mRNA and tissue level alterations can differentiate between typical and atypical antipsychotic drugs. Neuropsychopharmacology 23, 4655.
  • Benes F. M. (2000) Emerging principles of altered neural circuitry in schizophrenia. Brain Res. Brain Res. Rev. 31, 251269.
  • Benes F. M., McSparren J., Bird E. D., SanGiovanni J. P. and Vincent S. L. (1991) Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Arch. Gen. Psychiatry 48, 9961001.
  • Benes F. M., Vincent S. L., Marie A. and Khan Y. (1996) Up-regulation of GABAA receptor binding on neurons of the prefrontal cortex in schizophrenic subjects. Neuroscience 75, 10211031.
  • Bernstein H. G., Braunewell K. H., Spilker C., Danos P., Baumann B., Funke S., Diekmann S., Gundelfinger E. D. and Bogerts B. (2002) Hippocampal expression of the calcium sensor protein visinin-like protein-1 in schizophrenia. Neuroreport 13, 393396.
  • Braunewell K. H. and Gundelfinger E. D. (1999) Intracellular neuronal calcium sensor proteins: a family of EF-hand calcium-binding proteins in search of a function. Cell Tissue Res. 295, 112.
  • Brown P. O. and Botstein D. (1999) Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21, 3337.
  • Buchanan R. W., Vladar K., Barta P. E. and Pearlson G. D. (1998) Structural evaluation of the prefrontal cortex in schizophrenia. Am. J. Psychiatry 155, 10491055.
  • Bunney W. E. and Bunney B. G. (2000) Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia. Brain Res. Brain Res. Rev. 31, 138146.
  • Cullen P. J. and Lockyer P. J. (2002) Integration of calcium and Ras signalling. Nat. Rev. Mol. Cell Biol. 3, 339348.
  • Deutch A. Y. and Duman R. S. (1996) The effects of antipsychotic drugs on Fos protein expression in the prefrontal cortex: cellular localization and pharmacological characterization. Neuroscience 70, 377389.
  • Dragunow M., Robertson G. S., Faull R. L., Robertson H. A. and Jansen K. (1990) D2 dopamine receptor antagonists induce fos and related proteins in rat striatal neurons. Neuroscience 37, 287294.
  • Dresbach T., Burns M. E., O'Connor V., DeBello W. M., Betz H. and Augustine G. J. (1998) A neuronal Sec1 homolog regulates neurotransmitter release at the squid giant synapse. J. Neurosci. 18, 29232932.
  • Dudoit S., Yang Y. H., Callow M. J. and Speed T. P. (2000) Statistical Methods for Identifying Differentially Expressed Genes in Replicated cDNA Microarray Experiments. University of California, Berkeley, CA.
  • Glantz L. A. and Lewis D. A. (1997) Reduction of synaptophysin immunoreactivity in the prefrontal cortex of subjects with schizophrenia. Regional and diagnostic specificity [corrected and republished article originally appeared in Arch. Gen. Psychiatry 1997, 54, 660–9]. Arch. Gen. Psychiatry 54, 943952.
  • Gong C. X., Shaikh S., Grundke-Iqbal I. and Iqbal K. (1996) Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics. Brain Res. 741, 95102.
  • Hakak Y., Walker J. R., Li C., Wong W. H., Davis K. L., Buxbaum J. D., Haroutunian V. and Fienberg A. A. (2001) Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc. Natl Acad. Sci. USA 98, 47464751.
  • Herdegen T. and Leah J. D. (1998) Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins. Brain Res. Brain Res. Rev. 28, 370490.
  • Iacovelli L., Sallese M., Mariggio S. and De Blasi A. (1999) Regulation of G-protein-coupled receptor kinase subtypes by calcium sensor proteins. FASEB J. 13, 18.
  • Kajimoto Y., Shirakawa O., Kuno T., Nishino N. and Nakai H. (1995) Delayed changes in neural visinin-like calcium-binding protein gene expression caused by acute phencyclidine administration. J. Neural Transm. Gen. Sect. 100, 257262.
  • Kim T., Tao-Cheng J. H., Eiden L. E. and Loh Y. P. (2001) Chromogranin A, an ‘on/off’ switch controlling dense-core secretory granule biogenesis. Cell 106, 499509.
  • Kittler J. T., Grigorenko E. V., Clayton C., Zhuang S. Y., Bundey S. C., Trower M. M., Wallace D., Hampson R. and Deadwyler S. (2000) Large-scale analysis of gene expression changes during acute and chronic exposure to [delta]9-THC in rats. Physiol. Genomics 3, 175185.
  • Kohonen T. (1997) Self-Organizing Maps. Springer, Berlin.
  • Kontkanen O., Lakso M., Wong G. and Castrén E. (2002) Chronic antipsychotic drug treatment induces long-lasting expression of fos and jun family genes and activator protein 1 complex in the rat prefrontal cortex. Neuropsychopharmacology 27, 152162.
  • Kroesen S., Marksteiner J., Mahata S. K., Mahata M., Fischer-Colbrie R., Saria A., Kapeller I. and Winkler H. (1995) Effects of haloperidol, clozapine and citalopram on messenger RNA levels of chromogranins A and B and secretogranin II in various regions of rat brain. Neuroscience 69, 881891.
  • Loguinov A. V., Anderson L. M., Crosby G. J. and Yukhananov R. Y. (2001) Gene expression following acute morphine administration. Physiol. Genomics 6, 169181.
  • Merchant K. M. and Dorsa D. M. (1993) Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl Acad. Sci. USA 90, 34473451.
  • Merchant K. M., Figur L. M. and Evans D. L. (1996) Induction of c-fos mRNA in rat medial prefrontal cortex by antipsychotic drugs: role of dopamine D2 and D3 receptors. Cereb. Cortex 6, 561570.
  • Middleton F. A., Mirnics K., Pierri J. N., Lewis D. A. and Levitt P. (2002) Gene expression profiling reveals alterations of specific metabolic pathways in schizophrenia. J. Neurosci. 22, 27182729.
  • Miller J. C. (1990) Induction of c-fos mRNA expression in rat striatum by neuroleptic drugs. J. Neurochem. 54, 14531455.
  • Mimmack M. L., Ryan M., Baba H., Navarro-Ruiz J., Iritani S., Faull R. L., McKenna P. J., Jones P. B., Arai H., Starkey M., Emson P. C. and Bahn S. (2002) Gene expression analysis in schizophrenia: Reproducible up-regulation of several members of the apolipoprotein L family located in a high-susceptibility locus for schizophrenia on chromosome 22. Proc. Natl Acad. Sci. USA 99, 46804685.
  • Mirnics K., Middleton F. A., Marquez A., Lewis D. A. and Levitt P. (2000) Molecular characterization of schizophrenia viewed by microarray analysis of gene expression in prefrontal cortex. Neuron 28, 5367.
  • Nguyen T. V., Kosofsky B. E., Birnbaum R., Cohen B. M. and Hyman S. E. (1992) Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. Proc. Natl Acad. Sci. USA 89, 42704274.
  • Paxinos G. and Watson C. (1986) The Rat Brain in Stereotaxic Coordinates. Academic Press, Sydney.
  • Pevsner J., Hsu S. C., Braun J. E., Calakos N., Ting A. E., Bennett M. K. and Scheller R. H. (1994) Specificity and regulation of a synaptic vesicle docking complex. Neuron 13, 353361.
  • Rajkowska G., Selemon L. D. and Goldman-Rakic P. S. (1998) Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. Arch. Gen. Psychiatry 55, 215224.
  • Robertson G. S. and Fibiger H. C. (1992) Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience 46, 315328.
  • Robertson G. S., Matsumura H. and Fibiger H. C. (1994) Induction patterns of Fos-like immunoreactivity in the forebrain as predictors of atypical antipsychotic activity. J. Pharmacol. Exp. Ther. 271, 10581066.
  • Rusnak F. and Mertz P. (2000) Calcineurin: form and function. Physiol. Rev. 80, 14831521.
  • Schlaepfer T. E., Harris G. J., Tien A. Y., Peng L. W., Lee S., Federman E. B., Chase G. A., Barta P. E. and Pearlson G. D. (1994) Decreased regional cortical gray matter volume in schizophrenia. Am. J. Psychiatry 151, 842848.
  • Sebens J. B., Koch T., Ter Horst G. J. and Korf J. (1995) Differential Fos-protein induction in rat forebrain regions after acute and long-term haloperidol and clozapine treatment. Eur. J. Pharmacol. 273, 175182.
  • Selemon L. D., Rajkowska G. and Goldman-Rakic P. S. (1995) Abnormally high neuronal density in the schizophrenic cortex. A morphometric analysis of prefrontal area 9 and occipital area 17. Arch. Gen. Psychiatry 52, 805818; discussion 819–820.
  • Selemon L. D., Rajkowska G. and Goldman-Rakic P. S. (1998) Elevated neuronal density in prefrontal area 46 in brains from schizophrenic patients: application of a three-dimensional, stereologic counting method. J. Comp. Neurol. 392, 402412.
  • Südhof T. C. and Rizo J. (1996) Synaptotagmins: C2-domain proteins that regulate membrane traffic. Neuron 17, 379388.
  • Tamayo P., Slonim D., Mesirov J., Zhu Q., Kitareewan S., Dmitrovsky E., Lander E. S. and Golub T. R. (1999) Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc. Natl Acad. Sci. USA 96, 29072912.
  • Törönen P., Kolehmainen M., Wong G. and Castrén E. (1999) Analysis of gene expression data using self-organizing maps. FEBS Lett. 451, 142146.
  • Vawter, M. P., Barrett T., Cheadle C., Sokolov B. P., Wood W. H., 3rd Donovan D. M., Webster M., Freed W. J. and Becker K. G. (2001) Application of cDNA microarrays to examine gene expression differences in schizophrenia. Brain Res. Bull. 55, 641650.
  • Wisden W. and Morris B. J., eds (1994) In situ Hybridization with Synthetic Oligonucleotide Probes. Academic Press, London.
  • Yoo S. H. (2000) Coupling of the IP3 receptor/Ca2+ channel with Ca2+ storage proteins chromogranins A and B in secretory granules. Trends Neurosci. 23, 424428.
  • Zerial M. and McBride H. (2001) Rab proteins as membrane organizers. Nat. Rev. Mol. Cell Biol. 2, 107117.